What is known and objective: Treatment adherence is an essential component in ensuring best outcomes in the management of paediatric cancers. Compared to the adult population, treatment adherence in the paediatric population is a more complex subject which involves unique dimensions. In this study, we aimed to systematically review the literature to identify factors associated with treatment adherence in the paediatric oncology population. Methods: A literature search was carried out using related keywords on electronic databases. Results and discussion: A total of 1036 articles were reviewed, and 39 articles were found to be relevant. A comprehensive review of these articles identified 17 factors that influence adherence. These factors were classified into five major categories: patient-/caregiver-related factors; therapy-related factors; condition-related factors; health system-related factors; and social/economic factors. A baby bear model was proposed to better visualize these five categories that affect treatment adherence, and a framework of questions was designed to help clinicians identify those at risk of non-adherence for early intervention. What is new and conclusion: Seventeen factors reviewed were categorized into five main categories, namely patient-/caregiverrelated factors, therapy-related factors, condition-related factors, health system factors and social/economic factors, as causes for poor medication adherence in the paediatric oncology population. Clinicians need to be aware that these factors can interact to influence treatment adherence and that some factors may be more relevant in specific contexts (e.g. third world countries, minority groups). The baby bear model is presented to help understand the issues affecting adherence in the paediatric oncology population, and a framework of questions is proposed to help clinicians identify patients at risk of non-adherence.
1
According to participants at the World Health Organization (WHO) Adherence meeting in June 2001, adherence is defined by the 'extent to which a person's behaviour -taking medication, following a diet and/or executing lifestyle changes, corresponds with agreed recommendations from a healthcare provider'. 2 Breakthroughs in the effectiveness of treatment regimes would not translate to clinical results if patients are non-compliant. A recent review showed that approximately 21% of all patients with cancer do not adhere to their treatment. 3 Even more alarming is the fact that rate of non-adherence in the paediatric oncology population is even higher. For instance, studies have estimated that rates of non-adherence in patients with paediatric acute lymphoblastic leukaemia are between 2% and 60%. [4] [5] [6] Non-compliance to treatment in the paediatric oncological population has been associated with reduced treatment efficacy and increased risk of relapse. 7 Disruption of daily activities due to side effects 8 , poorer prognosis 9 , perceived inadequacies in the healthcare system 10 have been previously reported as factors that contribute to non-adherence in the general cancer population. However, the applicability of such studies to the patients with paediatric cancer should not be assumed, as factors that contribute to non-adherence in the paediatric oncology population may be very different from that of the general population. Identifying the factors that lead to treatment non-compliance in the paediatric oncology population may allow the development of strategies that can address these issues, leading to increased rates of treatment compliance.
Although there have been other systematic reviews addressing non-adherence to treatment, these have focused on the adult or geriatric population. [11] [12] [13] An extensive search of the literature did not show any recent studies that reviewed the factors associated with non-adherence to treatment in the paediatric oncology population. In view of this, we aimed to systematically review the current literature to identify factors associated with nonadherence in paediatric oncology patients.
METHODS
An electronic database was created using PubMed â and PsycINFO â with the keywords (adherence OR compliance) AND (oncology OR cancer OR malignancy OR tumour) AND (factors OR aspects OR elements OR components) AND (treatment OR chemo* OR radio* OR surgery OR medic* OR intervention) AND (paediatric* OR adolescents OR child*), and further manual searches were conducted using references of related articles. The literature review was current as of January 2016. The review inclusion criteria were peer-reviewed journals that studied the paediatric cancer population aged <18 years. The review excluded other reviews, meta-analyses and case reports.
Subsequently, factors affecting treatment adherence in this population of patients were categorized according to the WHO's dimensions of adherence 14 . This includes health system factors, social/economic factors, therapy-related factors, condition-related factors and patient-related factors. Finally, a bear model of treatment adherence in patients with paediatric cancer was proposed to help clinicians better visualize these five categories that affect treatment adherence, and a framework of questions was designed to help clinicians identify those at risk of non-adherence for early intervention.
RESULTS AND DISCUSSION
A total of 1036 articles were retrieved based on our keyword search. This included 960 articles from PubMed â and 76 articles from psycINFO â . Hand searches were also carried out using the references of related articles. A total of 46 articles met the inclusion criteria for our study, whereas the remaining 990 articles were not relevant. Seven duplicates were removed such that the final number of articles reviewed was 39 as shown in Fig. 1 .
Among the 39 articles reviewed, nine were cohort studies, 18 were cross-sectional studies, five were case series studies and seven were focused group discussion studies.
A total of 17 factors were identified and categorized based on the WHO's five dimensions of adherence. These five categories are patient-/caregiver-related factors, therapy-related factors, condition-related factors, health system factors and social/economic factors. In addition, the types and number of studies that support or do not support a particular factor were also identified.
The WHO defines patient-/caregiver-related factors as the resources, knowledge, attitudes, beliefs, perceptions and expectations of the patient; therapy-related factors as complexity of the medical regimen, duration of treatment, previous treatment failures, frequent changes in treatment, the immediacy of beneficial effects, side effects and the availability of medical support to deal with them; condition-related factors as particular illnessrelated demands faced by the patient; health system factors as the effects of healthcare team and system-related factors on adherence; social/economic factors as how socio-economic status affects adherence. 2 
Patient-/caregiver-related factors
A total of four main factors were identified under the patient-/ caregiver-related category. The number of studies and the type of studies that support each factor are shown in Table 1 . [4] [5] [6] The most cited factor in this category is 'patient's personality factors', which encompasses patient's coping behaviours, forgetfulness, personality traits, overdependence on parents, egocentrism, locus of control and yearning for normalcy. 'Patient's demographics' include patient's age, ethnicity and gender. 'Caregiver's and patient's disease and treatment perceptions' include disease perception and knowledge, and understanding of diagnosis/treatment. 'Caregiver issues' include parent's personality, parent and patient disagreements, caregiver negligence, lack of motivation and single parenthood.
Among patient-/caregiver-related factors, 'Patient's Personality Factors' was one of the common factors that was reported to cause non-adherence among patients in this category. Tamaroff et al. stated in a study that patients who deny or minimize the severity of their illness would be less likely to adhere to therapeutic treatments. This is especially seen in adolescences who perceive themselves as invulnerable or those who use defence mechanisms such as denial. In fact, it has been shown that in patients who comply to treatment, denial is virtually non-existent. 22 Other personality traits that adversely affect adherence to treatment include forgetfulness, poor coping behaviours such as blunting or avoidant coping traits, increased overdependence on caregivers for treatment adherence, as well as an increased yearning for normalcy. 6, 15, 31, 41 Another major factor that affects adherence is the age group of the patient. Manne et al. reported that younger children and children who are more functional are more likely to experience non-adherence especially with regard to procedure-based therapies such as mouth care, central line care and others. 20 Conversely, Jamison et al. showed that older adolescents were less adherent to treatment compared to younger adolescents, with the adolescent population defined as between 10 and 18 years old. 42 The reasons were postulated that adolescents are undergoing development and face many issues such as autonomy, independence and separation. 26 This could result in a transfer of treatment and medication responsibility between parent and patient, thus resulting in confusion and disagreements on who is responsible for treatment adherence. 15 Further research is required to elucidate the exact role of a patient's age in influencing adherence to treatment. 
Therapy-related factors
A total of three factors were identified under this category. The number of studies and the type of studies that support each factor are shown in Table 2 . 4, 16, [18] [19] [20] 23, 40, [43] [44] [45] Therapy-related factors that contribute to non-compliance include (i) side effects of therapy, (ii) length and complexity of treatment, and (iii) route of administration. Side effects of therapy were the most frequently reported factor leading to nonadherence. Children reported that they would be less motivated to comply with their treatment if its side effects cause disruption to their daily living. 43 In addition, Mancini also noted that parents of paediatric patients expressed concern regarding the adverse effects of therapy on their future well-being, and some even intentionally reduced the dose of medication for their children due to this worry. 4 Longer and more complex treatment regimes are expected to be associated with non-adherent behaviour. However, physicians were found to be more likely to put emphasis on the most critical drugs in complex regimes, possibly reducing the rate of omission of these medications. 45 In addition, Manne et al. noted that non-adherence to treatments and medications was reported to be higher in certain types of procedures. 20 Procedures that are more complex in nature or those that are perceived to be more painful and uncomfortable are likely to result in reduced adherence. Thus, a less painful and uncomfortable administration should always be preferred. Should there be no other alternative, efforts must be undertaken to reduce the distress caused when administering the medication or treatment.
Condition-related factors
A total of two factors were identified under this category. In this article, 'condition' refers to cancer. The number of studies and the type of studies that support each factor are shown in Table 3 . 6, 17, 23, 24 Condition-related factors comprise of (i) concrete thinking and (ii) poor prognosis. Concrete thinking is defined by the American Heritage Medical Dictionary (2007) as 'thinking characterized by a predominance of actual objects and events and the absence of concepts and generalizations'. Malbasa et al. 6 showed that many adolescents with non-adherent behaviour demonstrated such thinking. Normally, children will develop their thinking from concrete to abstract thinking quite early in adolescence. However, stressful situations such as the diagnosis of cancer can cause children and adolescents to regress back to concrete thinking, thus accounting for the prevalence of such thinking within nonadherent adolescents. Non-adherence is reinforced when the patient feels that their physical symptoms are improving despite not taking medication or when their doctors and healthcare providers announce good biochemical results. Such patients do not grasp the long-term implications of non-adherence, but rather develop the flawed conception between medication non-adherence and improving physical symptoms/biochemical test results. 6 A poorer prognosis has also been found to be associated with non-adherence. A study by Dolgin et al. illustrated the close association between non-adherence and cancer prognosis and outcome. Although it is unmistakable that non-adherence to treatment results in a poorer prognosis, the converse may not be as obvious to the patient. In addition, they suggested that a poorer initial prognosis in patients may result in excessive fear of discomfort and deformity as the disease progresses, leading to an increase in depression and denial which consequently impair adherence to treatment. 23 Health system factors A total of five factors were identified under the health system category. The number of studies and the type of studies that support each factor are shown in Table 4 . 6, [15] [16] [17] 40, [46] [47] [48] Health system-related factors include (i) failure to understand medical instructions, (ii) inadequate access to health insurance, (iii) poor healthcare provider communication and lack of supportive presence, (iv) perception of hospital care and (v) inadequate drug supply at pharmacy.
Notably, Tebbi et al. 15 stated that patient's understanding of medical instructions significantly correlated with adherence levels but cautioned that adherent and non-adherent patients did not differ significantly in their understanding of their disease, treatment or beliefs in the efficacy of the therapies and thus creating a mixed picture of support for the Health Belief Model.
Yeh et al. 16 suggested that one of the reasons leading to nonadherence to treatment is the lack of empathy, information and supportive presence of healthcare professionals. Under the stress of a life-threatening illness such as cancer in a child, caregivers often require information about the disease and treatments to better cope with the disease progression. It was noted that a lack of communication skills and empathy might result in caregivers either not adhering to treatment due to misinformation or choosing to discontinue treatment as they are frustrated by healthcare professionals and their attitudes.
Social/economic factors
A total of three factors were identified under the social/economic category. The number of studies and the type of studies that support each factor are shown in Table 5 . 5, [17] [18] [19] [20] [21] 46, 47, [49] [50] [51] [52] Social/economic factors comprise (i) financial difficulties, (ii) transportation issues and (iii) presence of more siblings. The majority of studies (14) reviewed under this category indicated that financial difficulties play a significant role in contributing to treatment non-adherence among the paediatric oncology population. One study by Bakhshi et al. 53 on treatment compliance in retinoblastoma found 'no significant association between sociodemographic features and compliance to treatment' as the authors claimed that the cost of treatment offered at their centre was relatively lower compared to others. However, we feel this is likely to be an exception rather than the rule given that most other studies found that lower socio-economic status was associated with non-adherence.
Notably, several studies highlighted that a lack of affordable transportation can negatively impact adherence to treatment. This factor featured prominently in patients coming from rural areas of developing countries, especially those from the lower socioeconomic classes. 15, 47, 50 Top factors based on frequency cited in studies Table 6 shows the top five factors based on frequency of citation in the articles reviewed in this study.
The most frequently cited factor associated with non-adherence to treatment is financial difficulties. There were 14 studies (involving cohort, cross-sectional, case series and focused group discussions) involving 3101 participants that identified financial difficulty as one of the key factors leading to non-adherence to treatment. As discussed above, measures to provide financial support to patients and caregivers will go a long way in improving adherence to treatment.
The second most commonly cited factor is the patient's personality. This encompasses patient's coping behaviours, forgetfulness, personality traits, overdependence on parents, egocentrism, locus of control and yearning for normalcy. This was identified in 11 studies involving 1540 participants. Based on its significance, it is therefore important to evaluate patient's personalities to identify traits that may adversely affect adherence to treatment especially in vulnerable populations such as adolescents.
The third most commonly cited factor is the demographics of the patient. A total of eight studies involving 9111 participants have identified the age group of the patient as one of the main factors influencing adherence to treatment. The maturity of the child was found to be correlated with the child's outlook and perception of the disease, thus playing a key role in influencing adherence.
The fourth most commonly cited factor is disease and treatment perceptions. Disease and treatment perceptions include caregiver's and patient's disease perception and knowledge, and understanding of diagnosis and treatment. Seven studies involving 503 people have shown that information and perception of the disease can affect the behaviours of both the caregivers and the patients, thus affecting treatment adherence. 23 The fifth most commonly cited factor is the adverse effect of treatment. Five studies involving 516 participants have identified adverse effects to be a critical determinant to treatment adherence.
Measures to detect non-adherence
To better help clinicians address the multiple factors of nonadherence, we have designed a framework of questions (Appendix S1) that clinicians can use by the bedside or in the clinic to better identify paediatric oncology patients at risk of nonadherence and intervene early. We recognize that factors contributing to non-adherence vary depending on the clinical context; thus, clinicians should determine the factors most relevant to their clinical practice and use the corresponding questions we have provided to screen for potential non-adherent behaviour.
Limitation
One limitation of this study is that even though we found that financial difficulty is the most commonly reported factor to be associated with non-adherence, we are unable to conclude whether this factor was most strongly associated with non-adherence in the paediatric oncology population, as this can only be addressed in a meta-analysis. Notwithstanding, as non-adherence to treatment is a multifactorial subject, we believe that there should not be a single factor that can account for this problem. Rather, we have classified the identified factors into the five WHO categories and designed a series of questions that clinicians can utilize to better understand and tackle the complex nature of non-adherence in this population. This would help facilitate the development of effective and appropriate intervention measures that can help reduce nonadherence, and hopefully decrease relapse rates in this population due to non-compliance to therapy.
WHAT IS NEW AND CONCLUSION
We have systematically reviewed the literature to identify factors that influence treatment adherence in the paediatric oncology population. To our knowledge, there were no prior reviews that addressed factors associated with adherence to the various treatment modalities in all types of cancers in the paediatric population. A baby bear model of adherence was designed to incorporate the five categories of factors identified in this review (Fig. 2) . We also developed a series of questions that can be used to help the clinician identify patients at risk of non-adherence, so that early intervention (such as referral to the medical social worker) can be taken to minimize these risks (Appendix S1). Finally, it is crucial for healthcare workers to communicate with the patient and their caregivers to understand their concerns and reasons for not adhering to treatment. The wishes, personal priorities and other social issues of the patient and their families must be addressed to help them play a more active role in treatment decisions, which will hopefully result in greater motivation and increased adherence to treatment.
